Clinical Trial Update: Neuroprotection and Repair in Optic Neuritis [Phase 2]

View source ↗

Summary

Phase 2 trial investigating neuroprotection and repair in optic neuritis was terminated. Conditions include multiple sclerosis and optic neuritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Optic Neuritis

Snippet

Sponsor: University of Calgary | Conditions: Multiple Sclerosis, Optic Neuritis | Phase 2 | Status: TERMINATED